Neuroimaging technique shows potential of bapineuzumab treatment and might be useful in assessing other drugs for Alzhei
A neuroimaging technique known as ¹¹C-PiB PET* shows that a new investigational drug, bapineuzumab,** reduces amyloid-β deposits in the brain by about 25% compared with placebo in patients who have mild-to-moderate ...
Feb 28, 2010
not rated yet
0
